Subscriber access provided by UNIVERSITY OF ADELAIDE LIBRARIES
Article
Absorption kinetics of the main CLA isomers in commercial rich oil after oral administration in rats Luis M. Rodríguez-Alcalá, Irma Ares, Javier Fontecha, María-Rosa Martínez-Larrañaga, Arturo Anadon, and María-Aránzazu Martínez J. Agric. Food Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jafc.7b02143 • Publication Date (Web): 09 Aug 2017 Downloaded from http://pubs.acs.org on August 11, 2017
Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
Journal of Agricultural and Food Chemistry is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.
Page 1 of 27
Journal of Agricultural and Food Chemistry
Absorption kinetics of the main CLA isomers in commercial rich oil after oral administration in rats
Luís M. Rodríguez-Alcalá1,3, Irma Ares2, Javier Fontecha1, María-Rosa Martínez-Larrañaga2, Arturo Anadón2 and María-Aránzazu Martínez2*
1
Instituto de Investigación en Ciencias de la Alimentación (CIAL, CSIC-UAM), C/
Nicolás Cabrera 9, Campus de Cantoblanco de la Universidad Autónoma de Madrid, 28049 Madrid, Spain 2
Department of Toxicology and Pharmacology, Faculty of Veterinary Medicine,
Universidad Complutense de Madrid, 28040 Madrid, Spain 3
Centro de Investigación en Recursos Naturales y Sustentabilidad (CIRENYS),
Universidad Bernardo O' Higgins, Fábrica Nº 1990, segundo piso, Santiago de Chile, Chile. _____________________________________________________________________ *Correspondence to: Professor María-Aránzazu Martínez, E-mail:
[email protected] Telephone: +34 91 3943834 _____________________________________________________________________
1 ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
Page 2 of 27
Abstract This study aimed to assess oral absorption and plasma kinetics of two main isomers contained in commercial CLA-rich oil (Tonalin TG-80), rumenic acid (RA) and C18:2 trans 10, cis 12. Isomer plasma disposition after single oral dose of 3000 mg Tonalin TG-80/kg, containing 1200 mg/kg of each isomer, was studied in rats. Isomer plasma concentrations were determined by GC-FID. Plasma kinetics showed rapid oral absorption of RA and C18:2 trans 10, cis 12 (t½a 0.34 ± 0.09 and 0.53 ± 0.01 h) and slow elimination (t½β 25.68 ± 3.29 and 18.12 ± 1.71 h); maximal isomer plasma concentrations (Cmax) of 8.48 ± 0.98 and 7.67 ± 0.80 µg mL-1, respectively, were estimated at 2.08 ± 0.14 and 2.26 ± 0.11 h. Our results from a pre-clinical kinetic study in rats help to design future studies in humans for evaluating CLA isomer dose-response
Keywords: CLA isomers; RA; C18:2 trans 10, cis 12; oral absorption; plasma disposition; rats
2 ACS Paragon Plus Environment
Page 3 of 27
Journal of Agricultural and Food Chemistry
1
INTRODUCTION
2 3
Conjugated linoleic acid (CLA) refers to a group of polyunsatured fatty acids that exist
4
as positional and stereo-isomers of conjugated linoleic acid (18:2). CLA is located
5
primarily in foods such as beef, lamb and dairy foods. Numerous beneficial biological
6
actions have been assigned to CLA.1,2,3 There is evidence that diets containing CLA
7
reduce adiposity in experimental animals and humans, although the potential
8
mechanisms by which CLA exert their effects through lipid metabolism parameters,
9
glucose metabolism and insulin sensitivity are not yet fully understood. In experimental
10
animals, it was also found that in pregnant rats after intake of a synthetic mixture of
11
CLA, the birthed pups had longer tails (pointing out to skeletal growth), weightier
12
gastrocnemius and soleus muscles, while similar adipose mass but smaller adipocyte
13
size.4 These data indicate that dietary CLA may also be valuable to certain growth
14
parameters.
15
In the literature, much attention has been aimed at these two main CLA isomers
16
contained in CLA-rich oils and their bioactivity. Rumenic acid (RA; C18:2 cis 9, trans
17
11) is the main CLA compound in dairy fat, associated to anticarcinogenic,
18
antiatherogenic, antidiabetic properties and stimulation of the immune system5,6 while
19
C18:2 trans 10, cis 12 seems to reduce body fat7 and is mostly present in these CLA
20
synthetic mixtures. Thus, in the present market there are available commercial CLA-
21
rich oils, obtained from the alkali isomerization of linoleic acid (LA) oils,8 with a level
22
of 77.7 g CLA per 100 g oil consisting in a 1:1 ratio of RA and C18:2 trans 10, cis 12 as
23
well as 5.6 g per100 g CLA oil of other minor isomers.9
24 25
Recent studies found that commercial CLA oil added to powder milk (0.96
g/kg
body
weight/day)
and
fed
to
rats
with
an
induced-by-diet 3
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
Page 4 of 27
26
hypercholesterolemic status can effectively decrease the triglycerides concentration in
27
blood while oral intake (0.46 g/kg body weight/day) of the oil alone decreased body
28
fat.10 Moreover, works carried out on humans using a dose of 90 g cheese/day (0.60 g
29
CLA/day) found increased plasma concentrations of RA, trans-vaccenic (TVA), alpha-
30
linolenic (ALA), arachidonic acid (AA) and eicosapentaenoic acid (EPA) together with
31
7% reduction in the level of LDL-cholesterol and endocannabinoid anandamid;11 similar
32
effects were described when assaying 0.80 g commercial CLA oil/day. In further
33
investigations, these later authors observed that feeding obese Zucker rats with a 1 %
34
CLA diet increased the concentration of docosahexaenoic fatty acid (DHA), N-
35
oleoylethanolamide (OEA) and N-palmitoylethanolamide (PEA) in liver.12 Such
36
compounds are associated to the induction of PPARα, a regulator of genes implicated in
37
peroxisomal β-oxidation, which seems to be activated by CLA.13
38
However, despite these above mentioned results, at the current moment, it also
39
exists an intense debate about the bioactivity of CLA isomers. Some further human and
40
animal research works reported contradictory effects without a clear association
41
between CLA intake and positive biological effects.14,15 Thus, overweight subjects
42
receiving dosages of 1.8 and 3.6 g/day showed regain of fat-free mass after weight
43
loss.16 This could be due to factors such as doses tested in humans must be much higher
44
than those tested in animals, metabolic differences associated among species or related
45
to the protocol used in the study. It has to be noted that the considered effective dose of
46
CLA in humans (3 g CLA/day) was proposed after extrapolation of data obtained from
47
animal studies focused in prevention of breast cancer.17 Moreover, McGowan et al.,18
48
reported that doses of 7.5 g CLA oil/day at least during 10 days in women reduced
49
expression of S14 ( regulator of the Acetyl-CoA carboxylase) and Ki-67 (proliferation
4 ACS Paragon Plus Environment
Page 5 of 27
Journal of Agricultural and Food Chemistry
50
marker) in breast cancer tissue. However, data about dose-response properties with
51
respect to plasma concentrations of CLA and cancer risk modulation are very scarce.
52
Therefore, CLA concentrations have to be used with caution. The European
53
Food Safety Authority (EFSA) suggested that CLA intake (up to 6 months) does not
54
seem to impair insulin sensitivity, blood glucose control or liver function; however,
55
although the reported effects on blood lipids are unlikely to negatively impact on
56
cardiovascular disease risk, long-term effects of CLA intake have not been sufficiently
57
assessed in humans.19 Some studies assaying the proposed safe doses reported
58
increment of inflammatory markers20 or LDL/HDL and total cholesterol/HDL ratios,21
59
hepatotoxicity22 and insulin resistance23 pointing out to C18:2 trans 10, cis 12.
60
However, these negative actions may be isolated cases, as they have not been reported
61
in other intervention studies.
62
Then, it is clear that to obtain reliable data about the biological effects of RA and
63
C18:2 trans 10, cis 12, these compounds have to be tested on the basis of their oral
64
absorption and plasma disposition, but at the current moment such information is
65
scarce. In a previous investigation, the authors of this work performed a study to
66
characterize for the first time the absorption of RA, TVA (a precursor of RA in the
67
mammary gland) and ALA (an essential polyunsaturated fatty acid [PUFA]) in rats after
68
a single oral dose of a goat milk fat naturally enriched in these fatty acids.24 The results
69
showed that TVA, RA and ALA were quickly absorbed and slowly eliminated; the
70
maximum concentrations were identified in liver > plasma > erythrocyte. The
71
importance of these research works is highlighted by data reported by Jedidi et al.,25
72
assaying the in vitro intestinal absorption of fatty acids from a 1 % or 3.5 % fat milk
73
using an in vitro simulator and where the fatty acid bioaccesibility depended on chain
74
length, presence of double bonds and the percentage of fat. Moreover, elsewhere it was
5 ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
Page 6 of 27
75
reported that ad libitum administration to Sprague-Dawley rats of diets (84 g fat/kg diet)
76
containing 0.5% of CLA (RA and C18:2 trans 10, cis 12; 1:1) during 16 weeks resulted
77
in a higher accumulation of RA than C18:2 trans 10, cis 12 in liver despite their
78
chemical similarities.26 Beyond absorption, few studies in experimental animals and
79
humans have also been conducted to determine differential biological effects of CLA in
80
relation to individual isomer dose, interval and duration of dietary CLA.
81
Therefore, the safety and efficacy in the use of these compounds require of in
82
vivo kinetic studies, as they will lead to a better adjustment of the experimental dosage
83
in future functional experiments. To date, plasma kinetic studies of CLA isomers are
84
scarce. Thus, the aim of the present research work was to evaluate oral absorption and
85
kinetic plasma behaviour of two main CLA isomers (RA and C18:2 trans 10, cis 12)
86
contained in a commercial CLA-rich oil (Tonalin TG-80) after its administration to rats
87
measuring isomer plasma concentrations using a sensitive analytical method.
88
89
MATERIALS AND METHODS
90 91
Chemicals. N,N-Dimethylformamide (HPLC grade), hexane (HPLC grade),
92
methanol (HPLC grade) and sulfuric acid (98 %) were purchased from LAB-SCAN
93
(Dublin, Ireland). Sodium bicarbonate (99 %), sodium methoxide (95 %) and
94
tritridecanoin (99 %) were obtained from Sigma (St. Louis, Missouri, USA). Glyceryl
95
tritridecanoate (99 %; TG-C13) and CLA isomers (purity 99 %; RA and C18:2 trans 10,
96
cis 12) were purchased from Nu-Chek Prep,Inc.(Elysian,Minnesota,USA). Commercial
97
CLA-rich oil (Tonalin TG-80; 80 % g CLA per 100 oil, 40 % RA and 40 % C18:2 trans
98
10, cis 12 according to own data) was purchased from BASF (Cognis, Illertissen,
6 ACS Paragon Plus Environment
Page 7 of 27
Journal of Agricultural and Food Chemistry
99 100
Germany). All other chemicals were of the highest quality grade and provided from commercial sources.
101
Animals and experimental design. The study was analyzed and approved
102
by the Ethics Committee on Animal Research of the Complutense University of Madrid.
103
Adult male Wistar rats (Charles River Inc., Margate, Kent, UK; 220-250 g) were used
104
in this study. The rats were individually housed in polycarbonate cages in a silent room
105
under a controlled temperature (22 ± 2 ºC), relative humidity (50 ± 10%) and 12 h
106
light/dark cycle (light from 08.00 to 20.00 h), with solid food (A04 rodent diet,
107
Scientific Animal Food & Engineering, SAFE, Augy, France) and water ad libitum. The
108
rats were randomly divided into seven experimental groups: six groups of 10 animals
109
each treated with Tonalin TG-80 orally, and one blank or control group of 5 animals
110
without any treatment. Animals were dispossessed of food for 12 h before single oral
111
dose of 3000 mg Tonalin TG-80/kg body weight, but were supplied water ad libitum.
112
Before dose administration, Tonalin TG-80 was kept in a water bath set to 30ºC to reach
113
a liquid state (897 kg per m3) and was dispensed by gavage in a volume of 0.84 mL
114
CLA oil/rat of 250 g body weight. The oral Tonalin TG-80 dose used of 3000 mg/kg
115
body weight was equivalent to 1200 mg/kg body weight of each CLA isomer. Oral dose
116
of 3000 mg Tonalin TG-80/kg body weight was chosed based on preceding experiments
117
where the dose and route of administration did not show any undesirable effects,
118
abnormal clinical signs as well as changes in behavioral, body weight, or in food and
119
water consumption in the animals (data not showed). Moreover, this dose was also
120
estimated to provide plasma concentrations of the CLA isomers to be above the level of
121
limit of quantification (LOQ) of the analytical method for both CLA isomers (RA and
122
C18:2 trans 10, cis 12).
7 ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
Page 8 of 27
123
Animals were sacrificed by cervical dislocation (one animal at each time) and
124
then blood samples at 15 min, 30 min, 1, 2, 4, 6, 8, 12, 24 and 48 h after oral dose of
125
Tonalin TG-80 were collected in heparinized tubes. Plasma was separated by
126
centrifugation and stored frozen at -80ºC until analysed.
127
Analysis of plasma samples. Plasma sample preparation. The
128
concentrations of RA and C18:2 trans 10, cis 12 in plasma were determined as fatty acid
129
methyl esters (FAME) using a one-step procedure according to Castro-Gomez et al.,27
130
with some modifications: 500 µL of plasma sample were spiked with 100 µL of
131
glyceryl tritridecanoate (1.44 µg/mL). Transterification reaction was carried out by
132
adding 2.5 mL methanolic sodium methoxide 0.5 M at 80 ºC during 10 min while
133
afterwards an esterification reaction was accomplished using 1.66 mL of N,N-
134
dimethylformamide and 3 mL 1M H2SO4 in methanol at 100 ºC for 30 min. After
135
cooling samples in ice, FAME were extracted using 1 mL of hexane and 1 min vortex
136
(waiting 5 min for the separation of layers), then adding 7,5 mL 6 % w/v Na2CO3 and
137
finally 3500 rpm, 10 min. at room temperature. Upper phase was collected and placed
138
into a vial to be analysed by gas chromatography with flame ionization detector (GC-
139
FID).
140
To prepare the standard curves, RA and C18:2 trans 10, cis 12 were diluted in
141
hexane to final concentrations into a range of 0.006 to 300 µg/mL in rat control plasma.
142
Promptly after adding the CLA isomer solution to the plasma, they were prepared for
143
analysis as above mentioned. The calibration curves were performed the same day as
144
the rat treated samples.
145
FAME analysis. The obtained FAME fraction, was injected (1 µL; 10:1 split
146
ratio) into a gas chromatograph (GC) 6890 Agilent (Palo Alto, CA, USA) coupled to a
147
flame ionization detector (FID) and a mass spectrometer (MS; Agilent 5973N) coupled 8 ACS Paragon Plus Environment
Page 9 of 27
Journal of Agricultural and Food Chemistry
148
to a CP-Sil88 capillary column (100 m x 0.25 mm i.d. x 0.2 mm, Chrompack,
149
Middelburg, The Netherlands) with working conditions according to Rodríguez-Alcalá
150
et al.28 The injection volume was 1 µL. MS was used to identify and FID to quantify the
151
CLA isomers by comparing the CLA oil supplement (Tonalin TG-80; FAME prepared
152
from 5 mg as described in analysis of plasma samples) and CLA standards. In these
153
conditions, LOD was 0.009 µg/mL and LOQ was 0.03 µg/mL.
154
Data analysis. Plasma CLA isomers (RA and C18:2 trans 10, cis 12)
155
concentrations versus time curves were fitted to two-compartment model using the
156
computer program Phoenix (Version 7.0; Pharsight Corporation, Mountain View, CA,
157
USA). This model was established for best fit based on a smaller value for the Akaike’s
158
Information Criterion.29 The two-compartment model was the best fit for the two CLA
159
isomers and it was used to determine the kinetic parameters.
160 161
Plasma concentration versus time curves of both CLA isomers after a single oral dose of Tonalin TG-80 were fitted to the following exponential equation:
162
C = A1 × e -αt + A2 × e -βt – A3 × e –Kat
163
where C is the plasma concentration of the compound; A1, A2 and A3 are mathematical
164
coefficients; α is the hybrid rate constant for the distribution phase; β is the hybrid rate
165
constant for the elimination terminal phase; and Ka the first-order absorption rate
166
constant, and t is the time.
167
Absorption half-life (t1/2a), half-life of α phase (t1/2α), half-life of β phase (t1/2β),
168
distribution rate constants for transfer of the CLA isomer from the central to the
169
peripheral compartment (K12) and from the peripheral to the central compartment (K21),
170
and the elimination rate constant (K10) were calculated by use of standard equations as
171
described.30,31
9 ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
172
Page 10 of 27
The area under the concentration-time curves (AUC) and the mean residence
173
time (MRT) were calculated as follows:
174
AUC = (A1/α) + (A2/β) – (A3/Ka)
175
MRT = [(A1/α2) + (A2/β2) – (A3/Ka2)] (1/AUC)
176
Maximum plasma concentration (Cmax) and the interval (time) from oral
177
administration until Cmax was detected (Tmax) was also estimated directly from the
178
concentration versus time curve.
179
Differences in pharmacokinetic data between RA and C18:2 trans 10 cis 12,
180
were analyzed for statistical significance by the paired Student’s t-test (GraphPad Prism
181
6). Differences of P0.05; **P